Your browser doesn't support javascript.
loading
Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition.
Nabet, Barzin Y; Esfahani, Mohammad S; Moding, Everett J; Hamilton, Emily G; Chabon, Jacob J; Rizvi, Hira; Steen, Chloe B; Chaudhuri, Aadel A; Liu, Chih Long; Hui, Angela B; Almanza, Diego; Stehr, Henning; Gojenola, Linda; Bonilla, Rene F; Jin, Michael C; Jeon, Young-Jun; Tseng, Diane; Liu, Cailian; Merghoub, Taha; Neal, Joel W; Wakelee, Heather A; Padda, Sukhmani K; Ramchandran, Kavitha J; Das, Millie; Plodkowski, Andrew J; Yoo, Christopher; Chen, Emily L; Ko, Ryan B; Newman, Aaron M; Hellmann, Matthew D; Alizadeh, Ash A; Diehn, Maximilian.
Affiliation
  • Nabet BY; Department of Radiation Oncology, Stanford University, Stanford, CA, USA; Stanford Cancer Institute, Stanford University, Stanford, CA, USA.
  • Esfahani MS; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, CA, USA.
  • Moding EJ; Department of Radiation Oncology, Stanford University, Stanford, CA, USA; Stanford Cancer Institute, Stanford University, Stanford, CA, USA.
  • Hamilton EG; Department of Radiation Oncology, Stanford University, Stanford, CA, USA; Program in Cancer Biology, Stanford University, Stanford, CA, USA.
  • Chabon JJ; Department of Radiation Oncology, Stanford University, Stanford, CA, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA.
  • Rizvi H; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Steen CB; Stanford Cancer Institute, Stanford University, Stanford, CA, USA.
  • Chaudhuri AA; Department of Radiation Oncology, Department of Genetics, Washington University School of Medicine, St. Louis, MO, USA.
  • Liu CL; Stanford Cancer Institute, Stanford University, Stanford, CA, USA; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, CA, USA.
  • Hui AB; Department of Radiation Oncology, Stanford University, Stanford, CA, USA; Stanford Cancer Institute, Stanford University, Stanford, CA, USA.
  • Almanza D; Department of Radiation Oncology, Stanford University, Stanford, CA, USA; Program in Cancer Biology, Stanford University, Stanford, CA, USA.
  • Stehr H; Department of Pathology, Stanford University, Stanford, CA, USA.
  • Gojenola L; Department of Pathology, Stanford University, Stanford, CA, USA.
  • Bonilla RF; Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
  • Jin MC; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, CA, USA.
  • Jeon YJ; Department of Radiation Oncology, Stanford University, Stanford, CA, USA; Stanford Cancer Institute, Stanford University, Stanford, CA, USA; Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, Republic of Korea.
  • Tseng D; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, CA, USA.
  • Liu C; Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Merghoub T; Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell School of Medicine, New York, NY, USA; Parker Institute for Cancer Immunotherapy at MSK
  • Neal JW; Stanford Cancer Institute, Stanford University, Stanford, CA, USA; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, CA, USA.
  • Wakelee HA; Stanford Cancer Institute, Stanford University, Stanford, CA, USA; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, CA, USA.
  • Padda SK; Stanford Cancer Institute, Stanford University, Stanford, CA, USA; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, CA, USA.
  • Ramchandran KJ; Stanford Cancer Institute, Stanford University, Stanford, CA, USA; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, CA, USA.
  • Das M; Stanford Cancer Institute, Stanford University, Stanford, CA, USA; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, CA, USA; Department of Medicine, VA Palo Alto Health Care System, Palo Alto, CA, USA.
  • Plodkowski AJ; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Yoo C; Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
  • Chen EL; Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
  • Ko RB; Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
  • Newman AM; Stanford Cancer Institute, Stanford University, Stanford, CA, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA; Department of Biomedical Data Science, Stanford University, Stanford, CA, USA.
  • Hellmann MD; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell School of Medicine, New York, NY, USA; Parker Institute for Cancer Immunotherapy at MSK, Memorial
  • Alizadeh AA; Stanford Cancer Institute, Stanford University, Stanford, CA, USA; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, CA, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA. Electronic address: a
  • Diehn M; Department of Radiation Oncology, Stanford University, Stanford, CA, USA; Stanford Cancer Institute, Stanford University, Stanford, CA, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA. Electronic address: diehn@stanford.edu.
Cell ; 183(2): 363-376.e13, 2020 10 15.
Article in En | MEDLINE | ID: mdl-33007267
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Pharmacological / Circulating Tumor DNA / Immune Checkpoint Inhibitors Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Cell Year: 2020 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Pharmacological / Circulating Tumor DNA / Immune Checkpoint Inhibitors Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Cell Year: 2020 Document type: Article Affiliation country: Country of publication: